Pharmacological inhibition of epsilon PKC suppresses chronic inflammation in murine cardiac transplantation model

Journal of Molecular and Cellular Cardiology

Volumn 43, Issue 4, 2007, Pages 517-522

  Koyanagi, Tomoyoshi ^a   Noguchi, Kenichiro ^a   Ootani, Akifumi ^a   Inagaki, Koichi ^a   Robbins, Robert C ^a   Mochly Rosen, Daria ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fibrosis; Inflammation; Protein kinase C; Signal transduction; Transplantation

Indexed keywords

CYCLOSPORIN A; EPSILON V1 2; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN KINASE C EPSILON; PROTEIN KINASE C INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIAC GRAFT REJECTION; CHRONIC INFLAMMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; GRAFT SURVIVAL; HEART FAILURE; HEART INFARCTION; HEART TRANSPLANTATION; IMMUNE RESPONSE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT OUTCOME;

ANIMALS; CHRONIC DISEASE; CYCLOSPORINE; DISEASE MODELS, ANIMAL; GRAFT REJECTION; GRAFT SURVIVAL; HEART FAILURE; HEART TRANSPLANTATION; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MYOCARDITIS; NEUTROPHIL INFILTRATION; PEPTIDE FRAGMENTS; PROTEIN KINASE C; PROTEIN KINASE C-EPSILON; PROTEIN KINASE INHIBITORS; T-LYMPHOCYTES; TRANSPLANTATION, HETEROTOPIC;

ANIMALIA; MURINAE; MUS;

EID: 34548815897     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.06.003     Document Type: Article

References (22)

1. Thom T., Haase N., Rosamond W., Howard V.J., Rumsfeld J., Manolio T., et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113 (2006) e85-e151
2. Taylor D.O., Edwards L.B., Mohacsi P.J., Boucek M.M., Trulock E.P., Keck B.M., et al. The registry of the International Society for Heart and Lung Transplantation: twentieth official adult heart transplant report-2003. J. Heart Lung Transplant. 22 (2003) 616-624
3. Tanaka M., Terry R.D., Mokhtari G.K., Inagaki K., Koyanagi T., Kofidis T., et al. Suppression of graft coronary artery disease by a brief treatment with a selective epsilonPKC activator and a deltaPKC inhibitor in murine cardiac allografts. Circulation 110 (2004) II194-II199
4. Tanaka M., Gunawan F., Terry R.D., Inagaki K., Caffarelli A.D., Hoyt G., et al. Inhibition of heart transplant injury and graft coronary artery disease after prolonged organ ischemia by selective protein kinase C regulators. J. Thorac. Cardiovasc. Surg. 129 (2005) 1160-1167
5. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9 (1995) 484-496
6. Smith B.L., and Mochly-Rosen D. Inhibition of protein kinase C function by injection of intracellular receptors for the enzyme. Biochem. Biophys. Res. Commun. 188 (1992) 1235-1240
7. Souroujon M.C., and Mochly-Rosen D. Peptide modulators of protein-protein interactions in intracellular signaling. Nat. Biotechnol. 16 (1998) 919-924
8. Chen L., Hahn H., Wu G., Chen C.H., Liron T., Schechtman D., et al. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 11114-11119
9. Inagaki K., Chen L., Ikeno F., Lee F.H., Imahashi K., Bouley D.M., et al. Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo. Circulation 108 (2003) 2304-2307
10. Inagaki K., Churchill E., and Mochly-Rosen D. Epsilon protein kinase C as a potential therapeutic target for the ischemic heart. Cardiovasc. Res. 70 (2006) 222-230
11. Hucho T.B., Dina O.A., and Levine J.D. Epac mediates a cAMP-to-PKC signaling in inflammatory pain: an isolectin B4(+) neuron-specific mechanism. J. Neurosci. 25 (2005) 6119-6126
12. Aksoy E., Goldman M., and Willems F. Protein kinase C epsilon: a new target to control inflammation and immune-mediated disorders. Int. J. Biochem. Cell Biol. 36 (2004) 183-188
13. Tanaka M., Mokhtari G.K., Balsam L.B., Cooke D.T., Kofidis T., Zwierzchonievska M., et al. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model. J. Heart Lung Transplant. 24 (2005) 446-453
14. Gray M.O., Karliner J.S., and Mochly-Rosen D. A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J. Biol. Chem. 272 (1997) 30945-30951
15. Corry R.J., Winn H.J., and Russell P.S. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and H-2 antigens in rejection. Transplantation 16 (1973) 343-350
16. Chen L., Wright L.R., Chen C.H., Oliver S.F., Wender P.A., and Mochly-Rosen D. Molecular transporters for peptides: delivery of a cardioprotective epsilonPKC agonist peptide into cells and intact ischemic heart using a transport system, R(7). Chem. Biol. 8 (2001) 1123-1129
17. Billingham M.E., Cary N.R., Hammond M.E., Kemnitz J., Marboe C., McCallister H.A., et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J. Heart Transplant. 9 (1990) 587-593
18. Tanaka M., Fujiwara H., Onodera T., Wu D.J., Hamashima Y., and Kawai C. Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. Br. Heart J. 55 (1986) 575-581
19. Kass M., and Haddad H. Cardiac allograft vasculopathy: pathology, prevention and treatment. Curr. Opin. Cardiol. 21 (2006) 132-137
20. Booz G.W., and Baker K.M. Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts. Cardiovasc. Res. 30 (1995) 537-543
21. Crews G.M., Erickson L., Pan F., Fisniku O., Jang M.S., Wynn C., et al. Down-regulation of TGF-beta and VCAM-1 is associated with successful treatment of chronic rejection in rats. Transplant. Proc. 37 (2005) 1926-1928
22. Aziz T.M., Burgess M.I., Haselton P.S., Yonan N.A., and Hutchinson I.V. Transforming growth factor beta and diastolic left ventricular dysfunction after heart transplantation: echocardiographic and histologic evidence. J. Heart Lung Transplant. 22 (2003) 663-673